FDA Inspection 1201815 - GlaxoSmithKline Biologicals Kft. - February 13, 2023

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This FDA Inspection record concerns GlaxoSmithKline Biologicals Kft., with an inspection on February 13, 2023, issued by the Center for Biologics Evaluation and Research, covering biologics.

Company: GlaxoSmithKline Biologicals Kft.
Inspection Date: February 13, 2023
Product Type: Biologics
Office: Center for Biologics Evaluation and Research

Open in Dashboard

ID · c5748a37-e9f3-4d62-bbd5-85a709d0645d